logo
Plus   Neg
Share
Email

Alexion Pharmaceuticals Inc. Q2 adjusted earnings Beat Estimates

Below are the earnings highlights for Alexion Pharmaceuticals Inc. (ALXN):

-Earnings: $459.8 million in Q2 vs. -$457.4 million in the same period last year.
-EPS: $2.04 in Q2 vs. -$2.05 in the same period last year.
-Excluding items, Alexion Pharmaceuticals Inc. reported adjusted earnings of $605.0 million or $2.64 per share for the period.
-Analysts projected $2.34 per share
-Revenue: $1.20 billion in Q2 vs. $1.05 billion in the same period last year.

-Guidance:
Full year EPS guidance: $9.65 to $9.85
Full year revenue guidance: $4.75 - $4.80 Bln

For comments and feedback contact: editorial@rttnews.com

Follow RTT